09/12/2019
Samyang Biopharm USA, Inc. and Talix Therapeutics NV Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic
Samyang Biopharm USA, Inc. a global biotech subsidiary of the Samyang Pharmaceuticals Corp. , announced today that the company has entered into a research collaboration with the exclusive option to a worldwide licensing agreement with Talix Therapeutics NV. Financial terms of the agreement were not disclosed. [...]